Provided by Tiger Trade Technology Pte. Ltd.

Liminatus Pharma LLC

0.2191
-0.0109-4.74%
Post-market: 0.2150-0.0041-1.87%19:59 EDT
Volume:3.93M
Turnover:877.97K
Market Cap:9.83M
PE:-0.51
High:0.2400
Open:0.2161
Low:0.2047
Close:0.2300
52wk High:33.66
52wk Low:0.1592
Shares:44.88M
Float Shares:9.56M
Volume Ratio:0.13
T/O Rate:41.10%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-0.4297
EPS(LYR):-0.4300
ROE:--
ROA:-62.65%
PB:-1.00
PE(LYR):-0.51

Loading ...

Liminatus Pharma FY25 net loss widens to $10.2 million; operating loss narrows to $3 million

Reuters
·
Apr 01

Liminatus Pharma plans Phase 1 trial of CD47 antibody IBA101 in lung cancer

Reuters
·
Mar 17

Liminatus Pharma Announces Planned Phase 1 Clinical Trial of Iba101, a Next-Generation Cd47 Blocking Antibody

THOMSON REUTERS
·
Mar 17

Liminatus Pharma Cuts Shareholder Meeting Quorum to One-Third

Reuters
·
Mar 05

Liminatus Pharma prices 13.8M shares at 29c in public offering

TIPRANKS
·
Feb 17

Liminatus Pharma Announces $4 Million Public Offering With Warrants

Reuters
·
Feb 17

Liminatus Pharma, Inc. Announces Pricing of $4.0 Million Public Offering

THOMSON REUTERS
·
Feb 17

Liminatus Pharma Inc - Offering Price Set at $0.29 per Share

THOMSON REUTERS
·
Feb 17

Iris Acquisition Corp. II Files Initial Statement of Beneficial Ownership; Manish C. Shah Listed as Director

Reuters
·
Feb 12

Iris Acquisition Corp. II Announces Publication of Unqualified Independent Audit Report

Reuters
·
Feb 11

NASD Most Active Issues

Dow Jones
·
Feb 10

BRIEF-Liminatus Pharma Enters Settlement Agreement With Clear Street LLC

Reuters
·
Feb 10

Liminatus Pharma Inc - to Issue 4 Mln Shares of Common Stock to Holder in Exchange for Surrender and Cancellation of 805,377 Warrants

THOMSON REUTERS
·
Feb 10

Liminatus Pharma Inc - on Feb 6, Co Enters Settlement Agreement With Clear Street Llc - SEC Filing

THOMSON REUTERS
·
Feb 10

Liminatus Pharma Issues 4 Million Unregistered Shares to Settle Litigation

Reuters
·
Feb 10

NASD Most Active Issues

Dow Jones
·
Feb 06

NASDAQ TRADE HALT VOLATILITY TRADING PAUSE AT 01:08 PM

Reuters
·
Feb 05

Liminatus Pharma Faces Nasdaq Delisting Risk Over Sub-$1 Share Price

Reuters
·
Jan 27

Liminatus Pharma Faces Nasdaq Delisting Over Market Value Rule Breach

Reuters
·
Nov 26, 2025

Liminatus Pharma, Inc. (Nasdaq: Limn) Signs Mou With Capital Trust Group for USD 30 Million Equity Investment via an Earn-Out Mechanism and Future Strategic Cooperation

THOMSON REUTERS
·
Oct 30, 2025